Prevalence and disease burden of chronic kidney disease
JC Lv, LX Zhang - Renal fibrosis: mechanisms and therapies, 2019 - Springer
Chronic kidney disease (CKD) has been recognized as a leading public health problem
worldwide. The global estimated prevalence of CKD is 13.4%(11.7–15.1%), and patients …
worldwide. The global estimated prevalence of CKD is 13.4%(11.7–15.1%), and patients …
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
A Levin, M Tonelli, J Bonventre, J Coresh, JA Donner… - The Lancet, 2017 - thelancet.com
The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …
Hypertension management in patients with cardiovascular comorbidities
L Lauder, F Mahfoud, M Azizi, DL Bhatt… - European Heart …, 2023 - academic.oup.com
Arterial hypertension is a leading cause of death globally. Due to ageing, the rising
incidence of obesity, and socioeconomic and environmental changes, its incidence …
incidence of obesity, and socioeconomic and environmental changes, its incidence …
[PDF][PDF] 2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz… - Arterial …, 2013 - journals.viamedica.pl
Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …
Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials
X Xie, Y Liu, V Perkovic, X Li, T Ninomiya… - American Journal of …, 2016 - Elsevier
Background There is much uncertainty regarding the relative effects of angiotensin-
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …
converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) in …
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal …
PA Sarafidis, A Persu, R Agarwal… - Nephrology dialysis …, 2017 - academic.oup.com
In patients with end-stage renal disease (ESRD) treated with haemodialysis or peritoneal
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
dialysis, hypertension is common and often poorly controlled. Blood pressure (BP) …
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the …
KL Lentine, SP Costa, MR Weir, JF Robb, LA Fleisher… - Circulation, 2012 - Am Heart Assoc
The challenges inherent in conducting accurate, clinically effective, and cost-effective
cardiac evaluations among transplantation candidates relate to the large size of the target …
cardiac evaluations among transplantation candidates relate to the large size of the target …
Chronic kidney disease
AS Levey, J Coresh - The lancet, 2012 - thelancet.com
Chronic kidney disease is a general term for heterogeneous disorders affecting kidney
structure and function. The 2002 guidelines for definition and classification of this disease …
structure and function. The 2002 guidelines for definition and classification of this disease …
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
G Mancia, S Laurent, E Agabiti-Rosei… - Blood …, 2009 - Taylor & Francis
GIUSEPPE MANCIAa, STÉPHANE LAURENTb, ENRICO AGABITI-ROSEIc, ETTORE
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …
Efficacy and safety of intradialytic exercise in haemodialysis patients: a systematic review and meta-analysis
J Pu, Z Jiang, W Wu, L Li, L Zhang, Y Li, Q Liu, S Ou - BMJ open, 2019 - bmjopen.bmj.com
Objective To assess the efficacy and safety of intradialytic exercise for haemodialysis
patients. Design Systematic review and meta-analysis. Data sources Databases, including …
patients. Design Systematic review and meta-analysis. Data sources Databases, including …